课题基金 / 基金详情

项目摘要

项目成果

DAVID A WILLIAMS的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
(PLEASE KEEP IN WORD, DO NOT PDF) Title: The role of Septin6 Group in Murine and Human Hematopoiesis 1 R01 DK137172-01 Septins are highly conserved GTPase proteins which regulate a variety of cellular functions including cytokinesis, polarity, cell cycle, vesicle trafficking, exocytosis, and creation of diffusion barriers. We have recently identified a non-syndromic newborn with severe neutropenia (Renella, AJH 2022) with a novel X-linked germline mutation in the C-terminus of SEPTIN6 gene (SEPTIN6 c.1282T>C p.428Glnext*9) associated with dysmyelopoiesis. Editing the germline mutation into normal male CD34+ hematopoietic stem and progenitor cells (HSC/P) phenocopied key pathologic features of the clinical syndrome, including large, multinucleated nuclei and reduced myeloid progenitor growth in vitro (preliminary data). The C-terminus has been proposed to play a key role in filament stabilization, bundling and bending as well as interactions with other septins and in silico modeling suggest the addition of 9 amino acids (aa) associated with the SEPTIN6 c.1282T>C p.428Glnext*9 mutation would alter function by interfering with SEPTIN6 protein interactions. Based on our initial publication, a second patient with severe neutropenia has since been identified in Seattle with a distinct mutation in the same codon (SEPTIN6 c.1282T>A) (Mohamad, Allensbach, Williams, accepted for presentation, ASH 2022). While the aa substitution is different, modeling predicts that SEPTIN6 variants adopt the same structure. Both identified patients had a high degree of myeloid tetraploidy in the marrow and were refractory to G-CSF.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Gene therapy targeting BCL11A to induce fetal hemoglobin and reduce sickle hemoglobin in patients with Sickle Cell Disease
  • 批准号:
    10083551
  • 项目类别:
  • 资助金额:
    $120.04万
  • 财政年份:
    2020
  • 负责人:
    DAVID A WILLIAMS
  • 依托单位:
Gene therapy targeting BCL11A to induce fetal hemoglobin and reduce sickle hemoglobin in patients with Sickle Cell Disease
  • 批准号:
    10179447
  • 项目类别:
  • 资助金额:
    $19.68万
  • 财政年份:
    2017
  • 负责人:
    DAVID A WILLIAMS
  • 依托单位:
Gene therapy targeting BCL11A to induce fetal hemoglobin and reduce sickle hemoglobin in patients with Sickle Cell Disease
  • 批准号:
    9363943
  • 项目类别:
  • 资助金额:
    $167.34万
  • 财政年份:
    2017
  • 负责人:
    DAVID A WILLIAMS
  • 依托单位:
ConProject-005
  • 批准号:
    10594167
  • 项目类别:
  • 资助金额:
    $7.42万
  • 财政年份:
    2016
  • 负责人:
    DAVID A WILLIAMS
  • 依托单位:
海外基金